Related references
Note: Only part of the references are listed.Proteomics: Technologies and Their Applications
Bilal Aslam et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2017)
Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3c
Leonardo Gomez Rosso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2017)
Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause
Roger A. Lobo et al.
ATHEROSCLEROSIS (2016)
microManaging glucose and lipid metabolism in skeletal muscle: Role of microRNAs
Julie Massart et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Effects of gender, age and menopausal status on serum apolipoprotein concentrations
Panagiotis Anagnostis et al.
CLINICAL ENDOCRINOLOGY (2016)
Focused Cardiovascular Care for Women: The Need and Role in Clinical Practice
Mariana Garcia et al.
MAYO CLINIC PROCEEDINGS (2016)
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease
Paolo Zanoni et al.
SCIENCE (2016)
Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences
Kui Yang et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Classification of LDL Phenotypes by 4 Methods of Determining Lipoprotein Particle Size
John J. Sninsky et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Marja-Riitta Taskinen et al.
ATHEROSCLEROSIS (2015)
A comparative study of four independent methods to measure LDL particle concentration
Paul N. Hopkins et al.
ATHEROSCLEROSIS (2015)
Pathophysiology of diabetic dyslipidaemia: where are we?
Bruno Verges
DIABETOLOGIA (2015)
Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions
Panagiotis Anagnostis et al.
MATURITAS (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sex Differences in Cardiovascular Mortality in Diabetics and Nondiabetic Subjects: A Population-Based Study (Italy)
Paola Ballotari et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Dyslipidemia and Cardiovascular Disease in Women
Renata Cifkova et al.
CURRENT CARDIOLOGY REPORTS (2015)
HDL cholesterol subclasses, myocardial infarction, and mortality in secondary prevention: the lipoprotein investigators collaborative
Seth S. Martin et al.
EUROPEAN HEART JOURNAL (2015)
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk
Anouar Hafiane et al.
BBA CLINICAL (2015)
Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects
Hajnalka Lorincz et al.
CLINICAL ENDOCRINOLOGY (2014)
ESC Guidelines on diabetes, pre- diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary
Lars Ryden et al.
DIABETES & VASCULAR DISEASE RESEARCH (2014)
Guidelines for the Prevention of Stroke in Women A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Cheryl Bushnell et al.
STROKE (2014)
Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review
Marouane Boukhris et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Narrowing Sex Differences in Lipoprotein Cholesterol Subclasses Following Mid-Life: The Very Large Database of Lipids (VLDL-10B)
Kristopher J. Swiger et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease
G. T. Russo et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2014)
High-Density Lipoprotein Subfractions - What the Clinicians Need to Know
Angela Pirillo et al.
CARDIOLOGY (2013)
Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women
Filipa Mascarenhas-Melo et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes
Jose Luis Sanchez-Quesada et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Sex Disparities in the Quality of Diabetes Care: Biological and Cultural Factors May Play a Different Role for Different Outcomes A cross-sectional observational study from the AMD Annals initiative
Maria Chiara Rossi et al.
DIABETES CARE (2013)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Lars Ryden et al.
EUROPEAN HEART JOURNAL (2013)
Apolipoprotein(a) Inhibits In Vitro Tube Formation in Endothelial Cells: Identification of Roles for Kringle V and the Plasminogen Activation System
Lei Liu et al.
PLOS ONE (2013)
Both Serum Apolipoprotein B and the Apolipoprotein B/Apolipoprotein A-I Ratio Are Associated with Carotid Intima-Media Thickness
Fei Huang et al.
PLOS ONE (2013)
Prevention and Treatment of Cardiovascular Disease in Women: The Obstetric-Gynecologist's Point of View
Giuseppina Perrone et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2013)
Age-Specific Gender Differences in In-Hospital Mortality by Type of Acute Myocardial Infarction
Zefeng Zhang et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Christopher K. Glass et al.
CELL METABOLISM (2012)
Proteomics Investigations of HDL: Challenges and Promise
Tomas Vaisar
CURRENT VASCULAR PHARMACOLOGY (2012)
High-density lipoprotein subclasses and their relationship to cardiovascular disease
H. Robert Superko et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Absolute Risk Reduction Due to Statin Use According to Sex
William J. Kostis
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Meta-Analysis of Statin Effects in Women Versus Men
William J. Kostis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study
Lei Kong et al.
ACTA DIABETOLOGICA (2011)
Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore Cohort
Paul T. Williams et al.
ATHEROSCLEROSIS (2011)
Heart Disease and Stroke Statistics-2011 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2011)
What Do the 2011 American Heart Association Guidelines Tell Us About Prevention of Cardiovascular Disease in Women?
Nanette K. Wenger
CLINICAL CARDIOLOGY (2011)
Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women
Angela H. E. M. Maas et al.
EUROPEAN HEART JOURNAL (2011)
Inflammatory links between obesity and metabolic disease
Carey N. Lumeng et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
Michael H. Davidson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
Stefania Lamon-Fava et al.
JOURNAL OF LIPID RESEARCH (2011)
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women-2011 Update A Guideline From the American Heart Association
Lori Mosca et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Restoration of High-Density Lipoprotein Levels by Cholesteryl Ester Transfer Protein Expression in Scavenger Receptor Class B Type I (SR-BI) Knockout Mice Does Not Normalize Pathologies Associated With SR-BI Deficiency
Reeni B. Hildebrand et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Representation of Women in Randomized Clinical Trials of Cardiovascular Disease Prevention
Chiara Melloni et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2010)
Lipoprotein subfractions and cardiovascular disease risk
Ronald M. Krauss
CURRENT OPINION IN LIPIDOLOGY (2010)
Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women
Samia Mora et al.
DIABETES (2010)
Proteomic analysis of electronegative low-density lipoprotein
Cristina Bancells et al.
JOURNAL OF LIPID RESEARCH (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Effect of hormone replacement therapy on plasma lipoprotein levels and coronary atherosclerosis progression in postmenopausal women according to type 2 diabetes mellitus status
Stefania Lamon-Fava et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Cardiovascular risk in women with diabetes
A. A. Rivellese et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2010)
Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
Stanley Ip et al.
ANNALS OF INTERNAL MEDICINE (2009)
Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters Relevance to Antioxidative Function
W. Sean Davidson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Comparability of methods for LDL subfraction determination: A systematic review
Mei Chung et al.
ATHEROSCLEROSIS (2009)
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
Daphne P. Guh et al.
BMC PUBLIC HEALTH (2009)
Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful
H. Robert Superko
CIRCULATION (2009)
Advanced Lipoprotein Testing and Subfractionation Are Not (Yet) Ready for Routine Clinical Use
Samia Mora
CIRCULATION (2009)
Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women
Samia Mora et al.
CIRCULATION (2009)
Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population
Justo Sierra-Johnson et al.
EUROPEAN HEART JOURNAL (2009)
Sex Differences in Mortality Following Acute Coronary Syndromes
Jeffrey S. Berger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Women and Ischemic Heart Disease Evolving Knowledge
Leslee J. Shaw et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis
Michael P. Caulfield et al.
CLINICAL CHEMISTRY (2008)
Diabetic Dyslipidemia and Atherosclerosis: Evidence from Clinical Trials
John A. Farmer
CURRENT DIABETES REPORTS (2008)
Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunction
Pascal Lovis et al.
DIABETES (2008)
Drugs for cardiovascular disease prevention in women - Implications of the AHA guidelines - 2007 update
Nanette K. Wenger
DRUGS (2008)
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
Matthew J. McQueen et al.
LANCET (2008)
Pancreatic Insulin Content Regulation by the Estrogen Receptor ERα
Paloma Alonso-Magdalena et al.
PLOS ONE (2008)
Potentially modifiable classic risk factors and their impact on incident myocardial infarction: results from the EPIC-Potsdam study
Christin Heidemann et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2007)
Cholesterol profile measurement by vertical auto profile method
Krishnaji R. Kulkarni
CLINICS IN LABORATORY MEDICINE (2006)
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
Elias J. Jeyarajah et al.
CLINICS IN LABORATORY MEDICINE (2006)
Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies
A Thompson et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Should we measure routinely the LDL peak particle size?
M Rizzo et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies
R Huxley et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women
S. R. Salpeter et al.
DIABETES OBESITY & METABOLISM (2006)
Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus
PWF Wilson et al.
CIRCULATION (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Menopausal hormone therapy: Currently no evidence for cardiac protection
NK Wenger
PEDIATRIC BLOOD & CANCER (2005)
Impact of hormone replacement therapy on microvascular function in healthy and Type 2 diabetic postmenopausal women
KM Gooding et al.
DIABETIC MEDICINE (2005)
Hormone therapy, lipoprotein subclasses, and coronary calcification - The healthy women study
RH Mackey et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes:: relationship to elevated oxidative stress and hyperglycaemia
E Nobécourt et al.
DIABETOLOGIA (2005)
Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer
V Michalaki et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
A new approach to the quantitative measurement of dense LDL subfractions
G Berg et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2004)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Lipids and lipoproteins in patients with type 2 diabetes
RM Krauss
DIABETES CARE (2004)
Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes
AR Scott et al.
DIABETES OBESITY & METABOLISM (2004)
Clinical review 163 - Cardiovascular endocrinology 4 - Low-density lipoprotein size and cardiovascular disease: A reappraisal
FM Sacks et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The effects of transdermal estradiol alone or with cyclical dydrogesterone on markers of cardiovascular disease risk in postmenopausal women with type 2 diabetes: A pilot study
ND Stojanovic et al.
ANGIOLOGY (2003)
Comparison of low-density lipoprotein size by polyacrylamide tube gel electrophoresis and polyacrylamide gradient gel electrophoresis
SV Hirany et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance
WT Garvey et al.
DIABETES (2003)
Lipoprotein abnormalities and their consequences for patients with Type 2 diabetes
AJ Krentz
DIABETES OBESITY & METABOLISM (2003)
Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women
GJ Blake et al.
CIRCULATION (2002)
Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women
CJ Crespo et al.
DIABETES CARE (2002)
Metabolic origins and clinical significance of LDL heterogeneity
KK Berneis et al.
JOURNAL OF LIPID RESEARCH (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families
ML Liu et al.
STROKE (2002)
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study
G Assmann et al.
CIRCULATION (2002)
Identification of novel genes coding for small expressed RNAs
M Lagos-Quintana et al.
SCIENCE (2001)
The effect of hormone replacement therapy on cardiovascular risk factors in type 2 diabetes - A randomized controlled trial
PJ Manning et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Oral 17β-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size
CC Tangney et al.
ATHEROSCLEROSIS (2001)
Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis
AP Burke et al.
AMERICAN HEART JOURNAL (2001)
Primary prevention of coronary heart disease in women through diet and lifestyle.
MJ Stampfer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
